A detailed history of Dt Investment Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Dt Investment Partners, LLC holds 745 shares of LLY stock, worth $592,774. This represents 0.05% of its overall portfolio holdings.

Number of Shares
745
Previous 670 11.19%
Holding current value
$592,774
Previous $606,000 8.91%
% of portfolio
0.05%
Previous 0.05%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$772.14 - $960.02 $57,910 - $72,001
75 Added 11.19%
745 $660,000
Q2 2024

Jul 24, 2024

BUY
$724.87 - $909.04 $11,597 - $14,544
16 Added 2.45%
670 $606,000
Q4 2023

Jan 31, 2024

BUY
$525.19 - $619.13 $16,806 - $19,812
32 Added 5.14%
654 $381,000
Q2 2023

Aug 28, 2023

BUY
$350.74 - $468.98 $3,858 - $5,158
11 Added 1.8%
622 $291,000
Q1 2023

May 03, 2023

BUY
$310.63 - $364.82 $124,252 - $145,928
400 Added 189.57%
611 $209,000
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $62,557 - $71,290
211 New
211 $68,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Dt Investment Partners, LLC Portfolio

Follow Dt Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dt Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dt Investment Partners, LLC with notifications on news.